← Back to Search

Staff Engagement Strategy for COVID-19 Vaccination (ENSPIRE Trial)

N/A

Waitlist Available

Led By Clarissa Hsu, PhD

Research Sponsored by Kaiser Permanente

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

18 years or older

Be older than 18 years old

Must not have

17 years or younger

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline (time 0); 7 months post-randomization (time 1); 10 months post-randomization (time 2); 13 months post-randomization (time 3)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing a communication and engagement strategy to see if it increases COVID-19 booster vaccination rates among facility staff. The strategy being tested includes developing materials tailored to staff whose primary language is not English or who are from certain cultural affinity groups, and distributing these materials by members of the same language/cultural affinity groups. The trial is being conducted in Washington state and Georgia.

Who is the study for?

This trial is for staff at long-term care facilities in Washington state or Georgia, with more than 50 employees and a COVID-19 booster vaccination rate of ≤60% as of December 1, 2021. Participants must be adults (18+). Staff from non-enrolled facilities or those under 18 are excluded.

What is being tested?

The ENSPIRE study compares a tailored communication strategy to increase COVID-19 booster rates against enhanced usual care using CDC materials. The full intervention includes custom materials and peer advocacy for diverse cultural/language groups.

What are the potential side effects?

Since this trial focuses on engagement strategies rather than medical interventions, there are no direct side effects from drugs or treatments being tested. However, participants may experience indirect effects related to the implementation of these strategies.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I am 17 years old or younger.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline (time 0); 7 months post-randomization (time 1); 10 months post-randomization (time 2); 13 months post-randomization (time 3)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline (time 0); 7 months post-randomization (time 1); 10 months post-randomization (time 2); 13 months post-randomization (time 3)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (time 0); 7 months post-randomization (time 1); 10 months post-randomization (time 2); 13 months post-randomization (time 3) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Secondary Immunization

Change in likelihood of recommending COVID-19 vaccination

Secondary study objectives

Change in COVID-19 vaccine confidence

Change in vaccine hesitancy

Other study objectives

Change in COVID-19 vaccine attitudes

Change in COVID-19 vaccine knowledge

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Full InterventionExperimental Treatment1 Intervention

Development of materials co-designed with and tailored to language/cultural affinity groups and distributed with assistance from co-design participants who will serve as peer advocates.

Group II: Enhanced Usual CareActive Control1 Intervention

Distribution of COVID-19 vaccine promotion materials from the Centers for Disease Control and Prevention \[CDC\] or other national organization with limited distribution support at long-term care centers.

0 / 2Eligibility criteria met